LEUCOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR NEUTRALIZING ANTIBODIES

This invention relates to agents that bind and neutralize the inhibitory activity of human ILT2 proteins having inhibitory activity in NK cells, T cells and/or other immune cells. Such agents can be used for the treatment of cancers or infectious disease. 本发明涉及结合并中和在NK细胞、T细胞和/或其它免疫细胞中具有抑制活性的人ILT2蛋白的...

Full description

Saved in:
Bibliographic Details
Main Authors CHANTEUX STEPHANIE, ROSSI BENJAMIN, PERROT IVAN, VIAUD NICOLAS, BENAC OLIVIER
Format Patent
LanguageChinese
English
Published 31.08.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention relates to agents that bind and neutralize the inhibitory activity of human ILT2 proteins having inhibitory activity in NK cells, T cells and/or other immune cells. Such agents can be used for the treatment of cancers or infectious disease. 本发明涉及结合并中和在NK细胞、T细胞和/或其它免疫细胞中具有抑制活性的人ILT2蛋白的抑制活性的药剂。此类药剂可以用于治疗癌症或感染性疾病。
Bibliography:Application Number: CN201980088822